Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of May 21, 2026, CHE trades at $441.61 with a market cap of $5.86B and a P/E ratio of 23.99. CHE moved +0.10% today. Year to date, CHE is +0.83%; over the trailing twelve months it is -24.05%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is neutral with an average price target of $446.50. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CHE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $441.61 |
| Market Cap | $5.86B |
| P/E Ratio | 23.99 |
| EPS | $18.36 |
| Dividend Yield | 0.60% |
| 52-Week High | $623.61 |
| 52-Week Low | $365.21 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.54B |
| Net Income | $259.78M |
| Gross Margin | 32.38% |
4 analysts cover CHE: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $446.50.